Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Jul 23, 2020 Theratechnologies Reports That Tesamorelin Improves Liver Health Jul 16, 2020 Announcements In Conjunction With Theratechnologies Annual Meeting Jul 15, 2020 Theratechnologies Announces Financial Results For The Second Quarter Of Fiscal 2020 Jul 07, 2020 Theratechnologies Confirms Bioequivalence Of New Tesamorelin Formulation Jul 06, 2020 Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro Jun 26, 2020 Theratechnologies To Announce Financial Results For Second Quarter 2020 Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers May 12, 2020 Theratechnologies To Present At The RBC Capital Markets Global Healthcare Conference On May 19, 2020 Apr 27, 2020 Theratechnologies Announces New Positive Results For Two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer First page « Previous page ‹ … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page › Last page » Displaying 151 - 160 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers
May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
May 12, 2020 Theratechnologies To Present At The RBC Capital Markets Global Healthcare Conference On May 19, 2020
Apr 27, 2020 Theratechnologies Announces New Positive Results For Two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer